Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia.

about

Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia.

Item

http://www.wikidata.org/entity/Q53704348

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Daptomycin and combination dap ...... phylococcus aureus bacteremia.

@en

Daptomycin and combination dap ...... phylococcus aureus bacteremia.

@nl

type

Item

label

Daptomycin and combination dap ...... phylococcus aureus bacteremia.

@en

Daptomycin and combination dap ...... phylococcus aureus bacteremia.

@nl

prefLabel

Daptomycin and combination dap ...... phylococcus aureus bacteremia.

@en

Daptomycin and combination dap ...... phylococcus aureus bacteremia.

@nl

P1476

Daptomycin and combination dap ...... phylococcus aureus bacteremia.

@en

P2093

Andrew Hunter

http://www.w3.org/2001/XMLSchema#string

Maria Rodriguez-Barradas

http://www.w3.org/2001/XMLSchema#string

Nicolas Cortes-Penfield

http://www.w3.org/2001/XMLSchema#string

Nora T Oliver

http://www.w3.org/2001/XMLSchema#string

P2860

Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.

Observation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains.

Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.

Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.

Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.

Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.

A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).

Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial

P304

1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/23744235.2018.1448110

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29508663

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus

P932

6109258

http://www.w3.org/2001/XMLSchema#string